HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
This Quarter Return
+2.43%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(-5.3%)
Cap. Flow
-$3.3M
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
30.31%
Holding
169
New
12
Increased
42
Reduced
105
Closed
10
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
$2.31M |
| 2 |
Fiserv
FI
|
$1.78M |
| 3 |
NextEra Energy, Inc.
NEE
|
$1.74M |
| 4 |
Progressive
PGR
|
$1.32M |
| 5 |
CyberArk
CYBR
|
$865K |
Top Sells
| 1 |
Salesforce
CRM
|
$2.34M |
| 2 |
Microsoft
MSFT
|
$1.69M |
| 3 |
Microchip Technology
MCHP
|
$1.37M |
| 4 |
PayPal
PYPL
|
$1.28M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$1.26M |
Sector Composition
| 1 | Technology | 46.95% |
| 2 | Healthcare | 25.4% |
| 3 | Consumer Discretionary | 14.36% |
| 4 | Communication Services | 6.93% |
| 5 | Utilities | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Eli Lilly
LLY
$657B
| $735K | 0.71% |
2,010
-43
| -2% | -$15.7K |
|
52
Cooper Companies
COO
$13.4B
| $716K | 0.69% |
2,164
-47
| -2% | -$15.5K |
|
|
BCYC
53
Bicycle Therapeutics
BCYC
$511M
| $715K | 0.69% |
24,147
-21,520
| -47% | -$637K |
|
54
Arrowhead Research
ARWR
$3.05B
| $694K | 0.67% |
17,122
-367
| -2% | -$14.9K |
|
55
Krystal Biotech
KRYS
$4.27B
| $673K | 0.65% |
8,501
-3,276
| -28% | -$260K |
|
56
UnitedHealth
UNH
$281B
| $670K | 0.65% |
+1,264
| New | +$670K |
|
57
Regenxbio
RGNX
$451M
| $605K | 0.59% |
26,685
-574
| -2% | -$13K |
|
58
Thermo Fisher Scientific
TMO
$186B
| $590K | 0.57% |
1,072
-23
| -2% | -$12.7K |
|
59
Lantheus
LNTH
$3.73B
| $589K | 0.57% |
11,557
-250
| -2% | -$12.7K |
|
60
Bio-Rad Laboratories Class A
BIO
$8.06B
| $565K | 0.55% |
1,343
-29
| -2% | -$12.2K |
|
61
Chart Industries
GTLS
$8.96B
| $562K | 0.54% |
+4,873
| New | +$562K |
|
62
Repare Therapeutics
RPTX
$71.7M
| $509K | 0.49% |
+34,572
| New | +$509K |
|
63
Dynatrace
DT
$15.3B
| $508K | 0.49% |
13,258
+11,112
| +518% | +$426K |
|
64
uniQure
QURE
$896M
| $500K | 0.49% |
22,067
-468
| -2% | -$10.6K |
|
65
Arvinas
ARVN
$568M
| $442K | 0.43% |
12,927
-277
| -2% | -$9.48K |
|
66
Zscaler
ZS
$43.1B
| $437K | 0.42% |
3,902
-1,113
| -22% | -$125K |
|
67
Meta Platforms (Facebook)
META
$1.86T
| $417K | 0.4% |
3,469
-4,637
| -57% | -$558K |
|
68
Zoom
ZM
$24.4B
| $371K | 0.36% |
5,477
-2
| -0% | -$135 |
|
69
Palo Alto Networks
PANW
$127B
| $334K | 0.32% |
+2,397
| New | +$334K |
|
70
Peloton Interactive
PTON
$3.1B
| $313K | 0.3% |
39,481
-223
| -0.6% | -$1.77K |
|
71
Intellia Therapeutics
NTLA
$1.22B
| $310K | 0.3% |
+8,886
| New | +$310K |
|
72
Sarepta Therapeutics
SRPT
$1.78B
| $296K | 0.29% |
+2,284
| New | +$296K |
|
73
Kymera Therapeutics
KYMR
$2.95B
| $291K | 0.28% |
11,678
-247
| -2% | -$6.17K |
|
|
AUTL
74
Autolus Therapeutics
AUTL
$399M
| $276K | 0.27% |
145,315
-3,139
| -2% | -$5.96K |
|
75
Allogene Therapeutics
ALLO
$251M
| $263K | 0.26% |
41,801
-19,493
| -32% | -$123K |
|